KATHERINE SHANAHAN: Open Payments
NPI 1346808383 · WILLIAMSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,267 in 99 payments from 6 companies in 2025. Trend: 2023 $748 · 2024 $905 · 2025 $1,267
Food & beverage: $1,267
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 32 | $403 |
| Janssen Biotech, Inc. | 42 | $376 |
| ABBVIE INC. | 13 | $277 |
| Madrigal Pharmaceuticals | 8 | $142 |
| PFIZER INC. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: TREMFYA, XIFAXAN, RELISTOR, SKYRIZI, REZDIFFRA, RINVOQ, VELSIPITY, CREON.
Industry payments across NY — which companies pay providers there.
